Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to -$19.0 million.

  • Altimmune's Consolidated Net Income rose 1676.95% to -$19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.0 million, marking a year-over-year increase of 1882.44%. This contributed to the annual value of -$95.1 million for FY2024, which is 752.99% down from last year.
  • Altimmune's Consolidated Net Income amounted to -$19.0 million in Q3 2025, which was up 1676.95% from -$22.1 million recorded in Q2 2025.
  • Over the past 5 years, Altimmune's Consolidated Net Income peaked at -$14.9 million during Q1 2021, and registered a low of -$33.5 million during Q3 2021.
  • Moreover, its 5-year median value for Consolidated Net Income was -$22.1 million (2025), whereas its average is -$22.4 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first crashed by 28253.86% in 2021, then skyrocketed by 2983.29% in 2022.
  • Over the past 5 years, Altimmune's Consolidated Net Income (Quarter) stood at -$23.9 million in 2021, then rose by 9.33% to -$21.7 million in 2022, then plummeted by 46.08% to -$31.6 million in 2023, then grew by 26.37% to -$23.3 million in 2024, then increased by 18.39% to -$19.0 million in 2025.
  • Its last three reported values are -$19.0 million in Q3 2025, -$22.1 million for Q2 2025, and -$19.6 million during Q1 2025.